Plasmanate Solution
Product Images NDC 13533-613

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Plasmanate (NDC 13533-613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton

Packaging label for Plasmanate, Plasma Protein Fraction (Human) 5% solution for intravenous use. Labeled strength is 5%, corresponding to 2.5 g per 50 mL concentration. The label specifies a 250 mL single-dose vial and includes storage and usage instructions. Labeler is Grifols USA, LLC, with NDC 13533-613-25.*

FDA Label Image

Label

Label for Plasmanate, Plasma Protein Fraction (Human) 5% solution, USP, 250 mL, by Grifols Therapeutics LLC. The label indicates heating to 60°C for 10 hours and specifies this is an intravenous single-dose vial. It includes storage instructions, electrolyte content per liter, and cautions about use after opening.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.